Article

Alternatives to mifepristone for early medical abortion.

Department of Obstetrics and Gynecology, Boston University School of Medicine, Boston, MA 02118, USA.
International Journal of Gynecology & Obstetrics (Impact Factor: 1.56). 04/2007; 96(3):212-8. DOI: 10.1016/j.ijgo.2006.09.009
Source: PubMed

ABSTRACT To review published reports of first-trimester medical abortion regimens that do not include mifepristone.
Reports listed in Pubmed and Medline on prospective and controlled trials of the efficacy of misoprostol, alone or associated with methotrexate, for first-trimester abortion were analyzed if they included more than 100 participants and were published since 1990.
The efficacy of regimens using misoprostol alone ranged from 84% to 96%, and when misoprostol was used with methotrexate the efficacy ranged from 70% to 97%. Efficacy rates were influenced by follow-up interval. Treatment for infection, bleeding, and incomplete abortion were infrequent with both methods (0.3%-5%).
Alone or in combination with methotrexate, misoprostol is an efficacious alternative to mifepristone for the medical termination of pregnancy.

Download full-text

Full-text

Available from: Ellen R Wiebe, Jun 26, 2015
0 Followers
 · 
189 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: In Zimbabwe, abortions are legally restricted and complications from unsafe abortions are a major public health concern. This study in 2012 explored women's and providers' perspectives in Zimbabwe on the acceptability of the use of misoprostol as a form of treatment for complications of abortion in post-abortion care. In-depth interviews were conducted with 115 participants at seven post-abortion care facilities. Participants included 73 women of reproductive age who received services for incomplete abortion and 42 providers, including physicians, nurses, midwives, general practitioners and casualty staff. Only 29 providers had previously used misoprostol with their own patients, and only 21 had received any formal training in its use. Nearly all women and providers preferred misoprostol to surgical abortion methods because it was perceived as less invasive, safer and more affordable. Women also generally preferred the non-surgical method, when given the option, as fears around surgery and risk were high. Most providers favoured removing legal restrictions on abortion, particularly medical abortion. Approving use of misoprostol for post-abortion care in Zimbabwe is important in order to reduce unsafe abortion and its related sequelae. Legal, policy and practice reforms must be accompanied by effective reproductive health curricula updates in medical, nursing and midwifery schools, as well as through updated training for current and potential providers of post-abortion care services nationwide. Our findings support the use of misoprostol in national post-abortion care programmes, as it is an acceptable and potentially life-saving treatment option. Copyright © 2015 Reproductive Health Matters. Published by Elsevier Ltd. All rights reserved.
    Reproductive Health Matters 02/2015; 22(44 Suppl 1). DOI:10.1016/S0968-8080(14)43792-3 · 1.37 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Reproductive Health Care For Women In Curacao: Induced Abortion And Contraception In countries where induced abortion is restricted by law, unsafe abortion is common. Curacao, part of the Kingdom of the Netherlands, has an autonomous status and independent legislation, in which induced abortion is rigorously restricted. The Public Prosecutor stipulated a tolerance policy in 1999 protecting personnel involved in abortion care from prosecution, but not women requesting abortion. Induced abortion on request of a woman is performed by 11 of 102 general practitioners. The aim of this thesis is to contribute to the discussion about reproductive and sexual health of women in Curaçao by studying induced abortion: the numbers, complications, methods and opinions of Curaçao women. Moreover, the opinions of women about contraceptive methods were examined in an attempt to clarify the cause of high number of unintended pregnancies and requests for abortion.. Main results: an abortion rate of at least 38 (Netherlands 8.6); hospital admissions due to complications comparable to South America, where abortion is also highly restricted; medical abortion, performed with mifepristone or methotrexate in combination with misoprostol or with misoprostol alone is safe and effective; although women need abortion frequently, they do not see abortion as contraceptive method and experience emotional problems afterwards. Most unintended pregnancies originate from no use or inconsistent use of reliable contraceptives, due to limited knowledge of and a cultural determined negative attitude toward contraception.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Objective: Evaluate implementation of misoprostol for postabortion care (MPAC) in two African countries. Design: Qualitative, program evaluation. Setting: Twenty-five public and private health facilities in Rift Valley Province, Kenya, and Kampala Province, Uganda. Sample: Forty-five MPAC providers, health facility managers, Ministry of Health officials, and non-governmental (NGO) staff involved in program implementation. Methods and main outcome measures: In both countries, the Ministry of Health, local health centers and hospitals, and NGO staff developed evidence-based service delivery protocols to introduce MPAC in selected facilities; implementation extended from January 2009 to October 2010. Semi-structured, in-depth interviews evaluated the implementation process, identified supportive and inhibitive policies for implementation, elicited lessons learned during the process, and assessed provider satisfaction and providers' impressions of client satisfaction with MPAC. Project reports were also reviewed. Results: In both countries, MPAC was easy to use, and freed up provider time and health facility resources traditionally necessary for provision of PAC with uterine aspiration. On-going support of providers following training ensured high quality of care. Providers perceived that many women preferred MPAC, as they avoided instrumentation of the uterus, hospital admission, cost, and stigma associated with abortion. Appropriate registration of misoprostol for use in the pilot, and maintaining supplies of misoprostol, were significant challenges to service provision. Support from the Ministry of Health was necessary for successful implementation; lack of country-based standards and guidelines for MPAC created challenges. Conclusions: MPAC is simple, cost-effective and can be readily implemented in settings with high rates of abortion-related mortality.
    Global Health Action 04/2013; 6:1-11. DOI:10.3402/gha.v6i0.19649 · 1.65 Impact Factor